CEDIA Benzodiazepine Assay

Enzyme Immunoassay, Benzodiazepine

Microgenics Corporation

The following data is part of a premarket notification filed by Microgenics Corporation with the FDA for Cedia Benzodiazepine Assay.

Pre-market Notification Details

Device IDK190968
510k NumberK190968
Device Name:CEDIA Benzodiazepine Assay
ClassificationEnzyme Immunoassay, Benzodiazepine
Applicant Microgenics Corporation 45600 Kato Road Fremont,  CA  94538
ContactMinoti Patel
CorrespondentMinoti Patel
Microgenics Corporation 45600 Kato Road Fremont,  CA  94538
Product CodeJXM  
CFR Regulation Number862.3170 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2019-04-12
Decision Date2019-12-09

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.